COMPARATIVE EFFECTIVENESS ABATACEPT, ADALIMUMAB AND RITUXIMAB IN PATIENTS WITH LONG-STANDING RHEUMATOID ARTHRITIS IN A REAL-LIFE SETTING

被引：0
|
作者：
Santos-Moreno, P. [1 ]
Villarreal, L. [2 ]
Ballesteros, G. [1 ]
Bello, J. [1 ]
Castillo, E. [1 ]
Giraldo, R. [1 ]
Gomez, D. [1 ]
Aza, A. [3 ]
Lopez, A. [4 ]
Cardozo, A. [3 ]
Palacio, N. [5 ]
Castro, C. [6 ]
Buitrago-Garcia, D. [6 ]
机构：
[1] Ctr Rheumatoid Arthrit, Rheumatol, Bogota, Colombia
[2] Ctr Rheumatoid Arthrit, Psychol, Bogota, Colombia
[3] Ctr Rheumatoid Arthrit, Hlth Serv, Bogota, Colombia
[4] Ctr Rheumatoid Arthrit, Bogota, Colombia
[5] Ctr Rheumatoid Arthrit, Nursing, Bogota, Colombia
[6] Ctr Rheumatoid Arthrit, Epidemiol, Biomab, Bogota, Colombia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.5640
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0369
引用
收藏
页码：1030 / 1030
页数：1
相关论文
共 50 条
  • [41] Results at 6 Months of Abatacept vs TNF-α Blockers in Patients with Severe, Long-standing, DMARDs Resistant Rheumatoid Arthritis
    Valenzuela, Omar
    Ibanez, Sebastian
    Paz Poblete, Maria
    Mardones, Claudia
    Silva, Francisco
    Jose Villar, Maria
    Mogollones, Katherine
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [42] Safety profile of repeated rituximab cycles in unselected rheumatoid arthritis patients: a long-term, prospective real-life study
    Vassilopoulos, D.
    Delicha, E. M.
    Settas, L.
    Andrianakos, A.
    Aslanidis, S.
    Boura, P.
    Katsounaros, M.
    Athanassiou, P.
    Tempos, K.
    Skarantavos, G.
    Antoniadis, C.
    Papazoglou, S.
    Sakkas, L.
    Galanopoulou, V.
    Skopouli, F.
    Boki, K.
    Daoussis, D.
    Vritzali, E.
    Sfikakis, P. P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (05) : 893 - 900
  • [43] Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia
    Deakin, Claire T.
    De Stavola, Bianca L.
    Littlejohn, Geoffrey
    Griffiths, Hedley
    Ciciriello, Sabina
    Youssef, Peter
    Mathers, David
    Bird, Paul
    Smith, Tegan
    O'Sullivan, Catherine
    Freeman, Tim
    Segelov, Dana
    Hoffman, David
    Seaman, Shaun R.
    JAMA NETWORK OPEN, 2023, 6 (06) : E2320851
  • [44] Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis
    Hirose, Wataru
    Harigai, Masayoshi
    Amano, Koichi
    Hidaka, Toshihiko
    Itoh, Kenji
    Aoki, Kazutoshi
    Nakashima, Masahiro
    Nagasawa, Hayato
    Komano, Yukiko
    Nanki, Toshihiro
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 6 (03)
  • [45] Monotherapy with Abatacept, Rituximab or Tocilizumab Is Not Associated with a Significantly Lower Long Term Retention Than Combination with Synthetic DMARD: Long-Term Registry Data in 4498 Real-Life Patients with Rheumatoid Arthritis
    Gottenberg, Jacques-Eric
    Morel, Jacques
    Constantin, Arnaud
    Bardin, Thomas
    Cantagrel, Alain G.
    Combe, Bernard
    Dougados, Maxime
    Flipo, Rene-Marc
    Saraux, Alain
    Schaeverbeke, Thierry
    Sibilia, Jean
    Soubrier, Martin
    Vittecoq, Olivier
    Perrodeau, Elodie
    Ravaud, Philippe
    Mariette, Xavier
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [46] Real-Life Effectiveness of Infliximab in the Treatment of Rheumatoid Arthritis: The Canadian Experience
    Choquette, Denis
    Bensen, William
    Khalil, Hayssam
    Sampalis, John
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1283 - 1283
  • [47] EFFECTIVENESS AND SAFETY OF BIOSIMILAR INFLIXIMAB (CT-P13) IN A REAL-LIFE SETTING IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Codreanu, C.
    Sirova, K.
    Jarosova, K.
    Batalov, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 489 - 489
  • [48] Effectiveness and safety of filgotinib in rheumatoid arthritis: a real-life multicentre experience
    La Barbera, L.
    Rizzo, C.
    Camarda, F.
    Atzeni, F.
    Miceli, G.
    Colella, A. B. Molica
    Franchina, V.
    Giardina, A.
    Corrao, S.
    Provenzano, G.
    Bursi, R.
    Foti, R.
    Dal Bosco, Y.
    Debilio, C.
    Luppino, F.
    Colaci, M.
    Aprile, M. L.
    Bentivegna, M.
    Cassara, E.
    Lo Gullo, A.
    De Andres, M. I.
    Guggino, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (05) : 991 - 998
  • [49] EFFECTIVENESS OF USING A TREAT TO TARGET STRATEGY IN A LARGE COHORT OF RHEUMATOID ARTHRITIS PATIENTS DURING 2 YEARS IN A REAL-LIFE SETTING
    Santos-Moreno, P.
    Sandoval, C.
    Villarreal, L.
    Real, A. P.
    Boon, P.
    Palomino, A.
    Urbina, A.
    Bello, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 604 - 604
  • [50] ADHERENCE RATE TO CONVENTIONAL DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS USING BIOLOGICS IN A REAL-LIFE SETTING
    Santos-Moreno, P.
    Villarreal, L.
    Sandoval, C.
    Real, A. P.
    Boon, P.
    Palomino, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 1030 - 1030
12345